康希诺生物：拟使用公积金弥补亏损

Core Viewpoint - The company plans to use its reserves to offset accumulated losses as of December 31, 2024, amounting to RMB 1.45 billion [1] Financial Summary - The company's accumulated losses amount to RMB 1.45 billion, with surplus reserves of RMB 118 million and capital reserves of RMB 6.577 billion [1] - The proposal includes using RMB 118 million from surplus reserves and RMB 1.332 billion from capital reserves to cover the losses [1] - After the proposed plan, surplus reserves will be reduced to RMB 0, capital reserves will decrease to RMB 5.245 billion, and accumulated losses will be fully offset to RMB 0 [1]